RGD Reference Report - Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation.

Authors: Molven, A  Matre, GE  Duran, M  Wanders, RJ  Rishaug, U  Njolstad, PR  Jellum, E  Sovik, O 
Citation: Molven A, etal., Diabetes. 2004 Jan;53(1):221-7.
RGD ID: 2306664
Pubmed: PMID:14693719   (View Abstract at PubMed)

Inappropriately elevated insulin secretion is the hallmark of persistent hyperinsulinemic hypoglycemia of infancy (PHHI), also denoted congenital hyperinsulinism. Causal mutations have been uncovered in genes coding for the beta-cell's ATP-sensitive potassium channel and the metabolic enzymes glucokinase and glutamate dehydrogenase. In addition, one hyperinsulinemic infant was recently found to have a mutation in the gene encoding short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), an enzyme participating in mitochondrial fatty acid oxidation. We have studied a consanguineous family with severe neonatal hypoglycemia due to increased insulin levels and where well-established genetic causes of hyperinsulinism had been eliminated. A genome-wide, microsatellite-based screen for homozygous chromosomal segments was performed. Those regions that were inherited in accordance with the presupposed model were searched for mutations in genes encoding metabolic enzymes. A novel, homozygous deletion mutation was found in the gene coding for the SCHAD enzyme. The mutation affected RNA splicing and was predicted to lead to a protein lacking 30 amino acids. The observations at the molecular level were confirmed by demonstrating greatly reduced SCHAD activity in the patients' fibroblasts and enhanced levels of 3-hydroxybutyryl-carnitine in their blood plasma. Urine metabolite analysis showed that SCHAD deficiency resulted in specific excretion of 3-hydroxyglutaric acid. By the genetic explanation of our family's cases of severe hypoglycemia, it is now clear that recessively inherited SCHAD deficiency can result in PHHI. This finding suggests that mitochondrial fatty acid oxidation influences insulin secretion by a hitherto unknown mechanism.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
HADHHumanCongenital Hyperinsulinism  IAGP DNA:deletion:cds (human)RGD 
HadhRatCongenital Hyperinsulinism  ISOHADH (Homo sapiens)DNA:deletion:cds (human)RGD 
HadhMouseCongenital Hyperinsulinism  ISOHADH (Homo sapiens)DNA:deletion:cds (human)RGD 

Objects Annotated

Genes (Rattus norvegicus)
Hadh  (hydroxyacyl-CoA dehydrogenase)

Genes (Mus musculus)
Hadh  (hydroxyacyl-Coenzyme A dehydrogenase)

Genes (Homo sapiens)
HADH  (hydroxyacyl-CoA dehydrogenase)


Additional Information